Clinical Trial Update: A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia [NA]

View source ↗

Summary

A multicenter randomized open-label study to evaluate Haplo-Cord hematopoietic stem cell transplantation for aplastic anemia; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Haplo-Cord HSCT

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Aplastic Anaemia | NA | Status: RECRUITING